Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karsten Witt

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Journal of Parkinson'S Disease|July 31, 2025
Progression to Parkinson's dementia is not modulated by genetic risk variants for Alzheimer's or Parkinson's diseaseKayenat Parveen, J Alexander Ross, Hendrik van der Wurp, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2022
Optimal deep brain stimulation sites and networks for cervical vs. generalized dystoniaAndreas Horn, Martin M Reich, Siobhan Ewert, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 21, 2017
Thalamic deep brain stimulation for orthostatic tremor: A multicenter international registryAristide Merola, Alfonso Fasano, Anhar Hassan, et al.
Brain : a Journal of Neurology|March 10, 2019
Probabilistic mapping of the antidystonic effect of pallidal neurostimulation: a multicentre imaging studyMartin M Reich, Andreas Horn, Florian Lange, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 20, 2021
Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessmentsAnja Ophey, Steffen Wolfsgruber, Sandra Roeske, et al.
Parkinsonism & Related Disorders|June 21, 2016
Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's diseaseDavid Mengel, Judith Dams, Jannis Ziemek, et al.
Brain, Behavior, and Immunity|June 10, 2025
Anti-VGLUT2 autoantibodies in neurological diseasesMerle Corty, Friederike A Arlt, Kathrin Borowski, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2018
Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognitionJennifer Wojtala, Ines Ann Heber, Petra Neuser, et al.
Neuroepidemiology|November 10, 2011
Parkinson's disease and dementia: a longitudinal study (DEMPARK)Monika Balzer-Geldsetzer, Ana Sofia Ferreira Braga da Costa, Martin Kronenbürger, et al.
The Lancet. Neurology|February 18, 2018
Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trialEugénie Lhommée, Lars Wojtecki, Virginie Czernecki, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Journal of Parkinson'S Disease|July 31, 2025
Progression to Parkinson's dementia is not modulated by genetic risk variants for Alzheimer's or Parkinson's diseaseKayenat Parveen, J Alexander Ross, Hendrik van der Wurp, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2022
Optimal deep brain stimulation sites and networks for cervical vs. generalized dystoniaAndreas Horn, Martin M Reich, Siobhan Ewert, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 21, 2017
Thalamic deep brain stimulation for orthostatic tremor: A multicenter international registryAristide Merola, Alfonso Fasano, Anhar Hassan, et al.
Brain : a Journal of Neurology|March 10, 2019
Probabilistic mapping of the antidystonic effect of pallidal neurostimulation: a multicentre imaging studyMartin M Reich, Andreas Horn, Florian Lange, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 20, 2021
Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessmentsAnja Ophey, Steffen Wolfsgruber, Sandra Roeske, et al.
Parkinsonism & Related Disorders|June 21, 2016
Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's diseaseDavid Mengel, Judith Dams, Jannis Ziemek, et al.
Brain, Behavior, and Immunity|June 10, 2025
Anti-VGLUT2 autoantibodies in neurological diseasesMerle Corty, Friederike A Arlt, Kathrin Borowski, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2018
Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognitionJennifer Wojtala, Ines Ann Heber, Petra Neuser, et al.
Neuroepidemiology|November 10, 2011
Parkinson's disease and dementia: a longitudinal study (DEMPARK)Monika Balzer-Geldsetzer, Ana Sofia Ferreira Braga da Costa, Martin Kronenbürger, et al.
The Lancet. Neurology|February 18, 2018
Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trialEugénie Lhommée, Lars Wojtecki, Virginie Czernecki, et al.
Pageof 14